Two of the genes, GFI1B and NFE2, have been implicated in blood diseases and traits29–31, and in our earlier work, we identified a broad transcriptional response to inhibition of GWAS-overlapping enhancers to these genes4. This evidence concerns the gene GFI1B and blood disease.